AstraZeneca PLC (AZN)
STRONG BUYUS listed
This page tracks AstraZeneca PLC (AZN) with live price data, technical indicators (RSI, MACD, moving averages, Sharpe ratio), and AI-powered analysis. Our scanner continuously reviews AZN against ~5,000 North American equities — fusing market fundamentals with frontier AI to surface high-conviction opportunities before they break out.
Latest AI Analysis
Updated Jun 22, 202668% confidenceAZN shows mixed technical setup with recent FDA catalysts offsetting near-term momentum weakness. The stock trades below its 50-day SMA ($186.52) following a sharp June selloff, but strong EPS growth (33.7% YoY) and two major regulatory wins (Truqap, Ultomiris) provide fundamental and catalyst support. Macro headwinds (Fear sentiment, sector volatility) and weak Sharpe ratio (0.13) temper conviction, warranting a measured BUY rather than STRONG_BUY confirmation.
Get the full picture for AZN — free.
Add AZN to a watchlist for instant scanner alerts. Run an on-demand 30-day AI price forecast. See the full historical signal track record. Free tier, no credit card.
Get scanner alerts and AI forecasts for AZN
Free tier includes daily AI recommendations, charts with indicators, and a 3-stock watchlist. No credit card.
Get Started →